|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/31/14 Bio Key International Inc 10-K 12/31/13 99:9.7M RDG Filings/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.14M
2: EX-10 Exhibit 10.35 HTML 95K
3: EX-10 Exhibit 10.36 HTML 95K
4: EX-10 Exhibit 10.37 HTML 93K
5: EX-10 Exhibit 10.38 HTML 94K
6: EX-10 Exhibit 10.39 HTML 93K
7: EX-10 Exhibit 10.40 HTML 45K
8: EX-10 Exhibit 10.41 HTML 43K
9: EX-10 Exhibit 10.42 HTML 100K
10: EX-10 Exhibit 10.43 HTML 40K
11: EX-10 Exhibit 10.44 HTML 57K
12: EX-23 Exhibit 23.1 HTML 28K
13: EX-31 Exhibit 31.1 HTML 38K
14: EX-31 Exhibit 31.2 HTML 38K
15: EX-32 Exhibit 32.1 HTML 32K
16: EX-32 Exhibit 32.2 HTML 31K
71: R1 Document And Entity Information HTML 56K
58: R2 Consolidated Balance Sheets HTML 102K
69: R3 Consolidated Balance Sheets (Parentheticals) HTML 37K
73: R4 Consolidated Statements of Operations HTML 83K
92: R5 Consolidated Statements of Stockholders' Equity HTML 68K
(Deficit)
60: R6 Consolidated Statements of Cash Flows HTML 119K
68: R7 Note A - The Company and Summary of Significant HTML 140K
Accounting Policies
52: R8 Note B - Factoring HTML 47K
42: R9 Note C - Fair Values of Financial Instruments HTML 74K
93: R10 Note D - Concentration of Risk HTML 55K
75: R11 Note E - Equipment and Leashold Improvements HTML 55K
74: R12 Note F - Intangible Assets HTML 60K
80: R13 Note G - Accrued Laibilites HTML 54K
81: R14 Note H - Related Party HTML 34K
78: R15 Note I - Deferred Revenue HTML 43K
82: R16 Note J - Notes Payable HTML 37K
70: R17 Note K - Segment Information HTML 36K
72: R18 Note L - Commitments HTML 44K
77: R19 Note M - Equity HTML 147K
99: R20 Note N - Stock Options HTML 184K
88: R21 Note O - Income Taxes HTML 81K
64: R22 Note P - Profit Sharing Plan HTML 30K
76: R23 Note Q - Earnings Per Share (Eps) HTML 58K
66: R24 Note R - Subsequent Events HTML 30K
34: R25 Accounting Policies, by Policy (Policies) HTML 197K
89: R26 Note A - The Company and Summary of Significant HTML 111K
Accounting Policies (Tables)
96: R27 Note B - Factoring (Tables) HTML 61K
47: R28 Note C - Fair Values of Financial Instruments HTML 70K
(Tables)
46: R29 Note D - Concentration of Risk (Tables) HTML 53K
50: R30 Note E - Equipment and Leashold Improvements HTML 53K
(Tables)
51: R31 Note F - Intangible Assets (Tables) HTML 58K
54: R32 Note G - Accrued Laibilites (Tables) HTML 52K
30: R33 Note I - Deferred Revenue (Tables) HTML 42K
86: R34 Note L - Commitments (Tables) HTML 40K
62: R35 Note M - Equity (Tables) HTML 100K
65: R36 Note N - Stock Options (Tables) HTML 177K
37: R37 Note O - Income Taxes (Tables) HTML 77K
98: R38 Note Q - Earnings Per Share (Eps) (Tables) HTML 55K
23: R39 Note A - The Company and Summary of Significant HTML 50K
Accounting Policies (Details)
55: R40 Note A - The Company and Summary of Significant HTML 36K
Accounting Policies (Details) - Summary of
Accounts Receivables
91: R41 Note A - The Company and Summary of Significant HTML 36K
Accounting Policies (Details) - Allowance for
Doubtful Accounts
36: R42 Note A - The Company and Summary of Significant HTML 36K
Accounting Policies (Details) - Estimated Useful
Lives for Depreciation and Amortization
45: R43 Note A - The Company and Summary of Significant HTML 33K
Accounting Policies (Details) - Share-Based
Compensation Expenses for Continuing Operations
49: R44 Note A - The Company and Summary of Significant HTML 39K
Accounting Policies (Details) - Valuation
Assumptions for Stock Options
59: R45 Note B - Factoring (Details) HTML 33K
29: R46 Note B - Factoring (Details) - Due from Factor HTML 33K
41: R47 Note C - Fair Values of Financial Instruments HTML 38K
(Details) - Fair Value Measurement of Warrant
Liabilities and Derivative Liabilities
25: R48 Note C - Fair Values of Financial Instruments HTML 41K
(Details) - Fair Value Measurements Using
Significant Unobservable Inputs
90: R49 Note D - Concentration of Risk (Details) HTML 29K
35: R50 Note D - Concentration of Risk (Details) - Revenue HTML 32K
Concentration Risk by Major Customer
87: R51 Note D - Concentration of Risk (Details) - HTML 32K
Accounts Receivable Concentration Risk by Major
Customer
38: R52 Note E - Equipment and Leashold Improvements HTML 30K
(Details)
56: R53 Note E - Equipment and Leashold Improvements HTML 40K
(Details) - Summary of Equipment and Leasehold
Improvements
24: R54 Note F - Intangible Assets (Details) HTML 45K
28: R55 Note F - Intangible Assets (Details) - Summary of HTML 36K
Intangible Assets
48: R56 Note G - Accrued Laibilites (Details) - Summary of HTML 55K
Accrued Liabilities
32: R57 Note H - Related Party (Details) HTML 35K
94: R58 Note I - Deferred Revenue (Details) - Components HTML 32K
of Deferred Revenue
61: R59 Note J - Notes Payable (Details) HTML 53K
79: R60 Note K - Segment Information (Details) HTML 33K
40: R61 Note L - Commitments (Details) HTML 29K
43: R62 Note L - Commitments (Details) - Future Minimum HTML 44K
Rental Commitments of Non-Cancelable Operating
Leases
85: R63 Note M - Equity (Details) HTML 146K
83: R64 Note M - Equity (Details) - Summary of Warrant HTML 49K
Activity
63: R65 Note N - Stock Options (Details) HTML 67K
84: R66 Note N - Stock Options (Details) - Option Activity HTML 89K
39: R67 Note N - Stock Options (Details) - Options HTML 56K
Outstanding and Exercisable
67: R68 Note O - Income Taxes (Details) HTML 30K
95: R69 Note O - Income Taxes (Details) - Components of HTML 49K
Deferred Taxes
27: R70 Note O - Income Taxes (Details) - Reconciliation HTML 34K
of the Effective Income Tax Rate to US Federal
Statutory Income Tax Rate
33: R71 Note P - Profit Sharing Plan (Details) HTML 29K
57: R72 Note Q - Earnings Per Share (EPS) (Details) - HTML 37K
Securities Excluded from the Diluted Per Share
Calculation
31: R73 Note R - Subsequent Events (Details) HTML 30K
97: XML IDEA XML File -- Filing Summary XML 133K
26: EXCEL IDEA Workbook of Financial Reports XLSX 179K
44: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.54M
17: EX-101.INS XBRL Instance -- bkyi-20131231 XML 1.69M
19: EX-101.CAL XBRL Calculations -- bkyi-20131231_cal XML 111K
20: EX-101.DEF XBRL Definitions -- bkyi-20131231_def XML 807K
21: EX-101.LAB XBRL Labels -- bkyi-20131231_lab XML 1.18M
22: EX-101.PRE XBRL Presentations -- bkyi-20131231_pre XML 766K
18: EX-101.SCH XBRL Schema -- bkyi-20131231 XSD 199K
53: ZIP XBRL Zipped Folder -- 0001437749-14-005560-xbrl Zip 180K
 | Download this Microsoft® Excel® .xls workbook |
| Web Archive: | This document is a Single File Web Page, also known as a Web Archive file. To view this Workbook file format, your browser or editor must support Web Archive files. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/30/24 Bio Key International Inc. S-1 5:346K RDG Filings/FA 10/26/23 Bio Key International Inc. S-1/A 9:1M RDG Filings/FA 10/16/23 Bio Key International Inc. S-1 4:473K RDG Filings/FA 6/15/23 Bio Key International Inc. S-1 136:12M RDG Filings/FA 4/01/22 Bio Key International Inc. 10-K 12/31/21 107:9.4M RDG Filings/FA 4/16/21 Bio Key International Inc. POS AM 3:2M RDG Filings/FA 3/29/21 Bio Key International Inc. 10-K 12/31/20 109:8.7M RDG Filings/FA |